Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-squamous Non-small-cell Lung Cancer × famitinib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2 Cervical Cancer Metastatic 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Non-squamous Non-small-cell Lung Cancer 1 Breast Neoplasms 1 Advanced Solid Tumor 1

Interventions

famitinib 1 camrelizumab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04619433 2025-09-23

A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Terminated

Non-squamous Non-small-cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡